Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …
Key advances in the clinical approach to ANCA-associated vasculitis
CGM Kallenberg - Nature Reviews Rheumatology, 2014 - nature.com
The updated nomenclature for vasculitis defines this varied group of disorders by aetiology,
specific features of pathogenesis and clinical symptoms; diagnostic and classification criteria …
specific features of pathogenesis and clinical symptoms; diagnostic and classification criteria …
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
In this article, the 2009 European League Against Rheumatism (EULAR) recommendations
for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis …
for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis …
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis
E Ntatsaki, D Carruthers, K Chakravarty… - …, 2014 - academic.oup.com
Eleana Ntatsaki1, 2, David Carruthers3, Kuntal Chakravarty4, David D'Cruz5, Lorraine
Harper6, David Jayne7, Raashid Luqmani8, John Mills9, Janice Mooney10, Michael …
Harper6, David Jayne7, Raashid Luqmani8, John Mills9, Janice Mooney10, Michael …
Adding azathioprine to remission‐induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg‐Strauss), microscopic polyangiitis, or polyarteritis …
Objective In most patients with nonsevere systemic necrotizing vasculitides (SNV s),
remission is achieved with glucocorticoids alone, but one‐third experience a relapse within …
remission is achieved with glucocorticoids alone, but one‐third experience a relapse within …
Virologic, clinical, and immune response outcomes of patients with hepatitis C virus–associated cryoglobulinemia treated with direct-acting antivirals
Background & Aims Cryoglobulins (circulating immune complexes of polyclonal IgG,
monoclonal IgM, and rheumatoid factor) are detected in the circulation of 40% to 60% of …
monoclonal IgM, and rheumatoid factor) are detected in the circulation of 40% to 60% of …
Efficacy and safety of belimumab and azathioprine for maintenance of remission in antineutrophil cytoplasmic antibody–associated vasculitis: a randomized controlled …
Objective To evaluate the safety and efficacy of belimumab as adjunctive therapy to maintain
remission in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) …
remission in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) …
IgG4 immune response in Churg–Strauss syndrome
A Vaglio, JD Strehl, B Manger, F Maritati… - Annals of the …, 2012 - ard.bmj.com
Objective T-helper type 2 responses are crucial in Churg–Strauss syndrome (CSS) and may
enhance the production of IgG4 antibodies. The authors assessed the IgG4 immune …
enhance the production of IgG4 antibodies. The authors assessed the IgG4 immune …
Glomerular hematuria and the utility of urine microscopy: a review
MK Saha, D Massicotte-Azarniouch… - American Journal of …, 2022 - Elsevier
Evaluation of hematuria and microscopic examination of urine sediment are commonly used
tools by nephrologists in their assessment of glomerular diseases. Certain morphological …
tools by nephrologists in their assessment of glomerular diseases. Certain morphological …
[HTML][HTML] Evaluation of the safety and efficacy of avacopan, a C5a receptor inhibitor, in patients with antineutrophil cytoplasmic antibody–associated vasculitis treated …
Background: Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a serious,
often life-threatening disease. In new-onset disease or a relapse, the standard treatment is …
often life-threatening disease. In new-onset disease or a relapse, the standard treatment is …